United States Biologics & Biosimilars Market Report 2018

January 2018 | 114 pages | ID: UB76CA0ED54EN
QYResearch

Abstracts

In this report, the United States Biologics & Biosimilars market is valued at USD XX million in 2017 and is expected to reach USD XX million by the end of 2025, growing at a CAGR of XX% between 2017 and 2025.

Geographically, this report splits the United States market into seven regions:

• The West
• Southwest
• The Middle Atlantic
• New England
• The South
• The Midwest
• with sales (volume), revenue (value), market share and growth rate of Biologics & Biosimilars in these regions, from 2013 to 2025 (forecast).

United States Biologics & Biosimilars market competition by top manufacturers/players, with Biologics & Biosimilars sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including

• fizer
• Roche
• Amgen
• AbbVie
• Sanofi
• Johnson & Johnson
• Novo Nordisk
• Novartis
• Merck
• Lilly
• 3sbio
• Changchun High Tech
• CP Guojian Pharmacy
• Biotech Pharma
• Gelgen Biopharma
• Sandoz
• Teva
• Hospira
• Mylan

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into

• Antibiotic
• Enzyme
• Hormone
• Non-Patented Biological Reagents
• Other

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including

• Tumor
• Diabetes
• Cardiovascular
• Hemophilia
• Other

If you have any special requirements, please let us know and we will offer you the report as you want.

Contents

United States Biologics & Biosimilars Market Report 2018

1 BIOLOGICS & BIOSIMILARS OVERVIEW

1.1 Product Overview and Scope of Biologics & Biosimilars
1.2 Classification of Biologics & Biosimilars by Product Category
  1.2.1 United States Biologics & Biosimilars Market Size (Sales Volume) Comparison by Type (2013-2025)
  1.2.2 United States Biologics & Biosimilars Market Size (Sales Volume) Market Share by Type (Product Category) in 2017
  1.2.3 Antibiotic
  1.2.4 Enzyme
  1.2.5 Hormone
  1.2.6 Non-Patented Biological Reagents
  1.2.7 Other
1.3 United States Biologics & Biosimilars Market by Application/End Users
  1.3.1 United States Biologics & Biosimilars Market Size (Consumption) and Market Share Comparison by Application (2013-2025)
  1.3.2 Tumor
  1.3.3 Diabetes
  1.3.4 Cardiovascular
  1.3.5 Hemophilia
  1.3.6 Other
1.4 United States Biologics & Biosimilars Market by Region
  1.4.1 United States Biologics & Biosimilars Market Size (Value) Comparison by Region (2013-2025)
  1.4.2 The West Biologics & Biosimilars Status and Prospect (2013-2025)
  1.4.3 Southwest Biologics & Biosimilars Status and Prospect (2013-2025)
  1.4.4 The Middle Atlantic Biologics & Biosimilars Status and Prospect (2013-2025)
  1.4.5 New England Biologics & Biosimilars Status and Prospect (2013-2025)
  1.4.6 The South Biologics & Biosimilars Status and Prospect (2013-2025)
  1.4.7 The Midwest Biologics & Biosimilars Status and Prospect (2013-2025)
1.5 United States Market Size (Value and Volume) of Biologics & Biosimilars (2013-2025)
  1.5.1 United States Biologics & Biosimilars Sales and Growth Rate (2013-2025)
  1.5.2 United States Biologics & Biosimilars Revenue and Growth Rate (2013-2025)

2 UNITED STATES BIOLOGICS & BIOSIMILARS MARKET COMPETITION BY PLAYERS/SUPPLIERS

2.1 United States Biologics & Biosimilars Sales and Market Share of Key Players/Suppliers (2013-2018)
2.2 United States Biologics & Biosimilars Revenue and Share by Players/Suppliers (2013-2018)
2.3 United States Biologics & Biosimilars Average Price by Players/Suppliers (2013-2018)
2.4 United States Biologics & Biosimilars Market Competitive Situation and Trends
  2.4.1 United States Biologics & Biosimilars Market Concentration Rate
  2.4.2 United States Biologics & Biosimilars Market Share of Top 3 and Top 5 Players/Suppliers
  2.4.3 Mergers & Acquisitions, Expansion in United States Market
2.5 United States Players/Suppliers Biologics & Biosimilars Manufacturing Base Distribution, Sales Area, Product Type

3 UNITED STATES BIOLOGICS & BIOSIMILARS SALES (VOLUME) AND REVENUE (VALUE) BY REGION (2013-2018)

3.1 United States Biologics & Biosimilars Sales and Market Share by Region (2013-2018)
3.2 United States Biologics & Biosimilars Revenue and Market Share by Region (2013-2018)
3.3 United States Biologics & Biosimilars Price by Region (2013-2018)

4 UNITED STATES BIOLOGICS & BIOSIMILARS SALES (VOLUME) AND REVENUE (VALUE) BY TYPE (PRODUCT CATEGORY) (2013-2018)

4.1 United States Biologics & Biosimilars Sales and Market Share by Type (Product Category) (2013-2018)
4.2 United States Biologics & Biosimilars Revenue and Market Share by Type (2013-2018)
4.3 United States Biologics & Biosimilars Price by Type (2013-2018)
4.4 United States Biologics & Biosimilars Sales Growth Rate by Type (2013-2018)

5 UNITED STATES BIOLOGICS & BIOSIMILARS SALES (VOLUME) BY APPLICATION (2013-2018)

5.1 United States Biologics & Biosimilars Sales and Market Share by Application (2013-2018)
5.2 United States Biologics & Biosimilars Sales Growth Rate by Application (2013-2018)
5.3 Market Drivers and Opportunities

6 UNITED STATES BIOLOGICS & BIOSIMILARS PLAYERS/SUPPLIERS PROFILES AND SALES DATA

6.1 fizer
  6.1.1 Company Basic Information, Manufacturing Base and Competitors
  6.1.2 Biologics & Biosimilars Product Category, Application and Specification
    6.1.2.1 Product A
    6.1.2.2 Product B
  6.1.3 fizer Biologics & Biosimilars Sales, Revenue, Price and Gross Margin (2013-2018)
  6.1.4 Main Business/Business Overview
6.2 Roche
  6.2.2 Biologics & Biosimilars Product Category, Application and Specification
    6.2.2.1 Product A
    6.2.2.2 Product B
  6.2.3 Roche Biologics & Biosimilars Sales, Revenue, Price and Gross Margin (2013-2018)
  6.2.4 Main Business/Business Overview
6.3 Amgen
  6.3.2 Biologics & Biosimilars Product Category, Application and Specification
    6.3.2.1 Product A
    6.3.2.2 Product B
  6.3.3 Amgen Biologics & Biosimilars Sales, Revenue, Price and Gross Margin (2013-2018)
  6.3.4 Main Business/Business Overview
6.4 AbbVie
  6.4.2 Biologics & Biosimilars Product Category, Application and Specification
    6.4.2.1 Product A
    6.4.2.2 Product B
  6.4.3 AbbVie Biologics & Biosimilars Sales, Revenue, Price and Gross Margin (2013-2018)
  6.4.4 Main Business/Business Overview
6.5 Sanofi
  6.5.2 Biologics & Biosimilars Product Category, Application and Specification
    6.5.2.1 Product A
    6.5.2.2 Product B
  6.5.3 Sanofi Biologics & Biosimilars Sales, Revenue, Price and Gross Margin (2013-2018)
  6.5.4 Main Business/Business Overview
6.6 Johnson & Johnson
  6.6.2 Biologics & Biosimilars Product Category, Application and Specification
    6.6.2.1 Product A
    6.6.2.2 Product B
  6.6.3 Johnson & Johnson Biologics & Biosimilars Sales, Revenue, Price and Gross Margin (2013-2018)
  6.6.4 Main Business/Business Overview
6.7 Novo Nordisk
  6.7.2 Biologics & Biosimilars Product Category, Application and Specification
    6.7.2.1 Product A
    6.7.2.2 Product B
  6.7.3 Novo Nordisk Biologics & Biosimilars Sales, Revenue, Price and Gross Margin (2013-2018)
  6.7.4 Main Business/Business Overview
6.8 Novartis
  6.8.2 Biologics & Biosimilars Product Category, Application and Specification
    6.8.2.1 Product A
    6.8.2.2 Product B
  6.8.3 Novartis Biologics & Biosimilars Sales, Revenue, Price and Gross Margin (2013-2018)
  6.8.4 Main Business/Business Overview
6.9 Merck
  6.9.2 Biologics & Biosimilars Product Category, Application and Specification
    6.9.2.1 Product A
    6.9.2.2 Product B
  6.9.3 Merck Biologics & Biosimilars Sales, Revenue, Price and Gross Margin (2013-2018)
  6.9.4 Main Business/Business Overview
6.10 Lilly
  6.10.2 Biologics & Biosimilars Product Category, Application and Specification
    6.10.2.1 Product A
    6.10.2.2 Product B
  6.10.3 Lilly Biologics & Biosimilars Sales, Revenue, Price and Gross Margin (2013-2018)
  6.10.4 Main Business/Business Overview
6.11 3sbio
6.12 Changchun High Tech
6.13 CP Guojian Pharmacy
6.14 Biotech Pharma
6.15 Gelgen Biopharma
6.16 Sandoz
6.17 Teva
6.18 Hospira
6.19 Mylan

7 BIOLOGICS & BIOSIMILARS MANUFACTURING COST ANALYSIS

7.1 Biologics & Biosimilars Key Raw Materials Analysis
  7.1.1 Key Raw Materials
  7.1.2 Price Trend of Key Raw Materials
  7.1.3 Key Suppliers of Raw Materials
  7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
  7.2.1 Raw Materials
  7.2.2 Labor Cost
  7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Biologics & Biosimilars

8 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

8.1 Biologics & Biosimilars Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Biologics & Biosimilars Major Manufacturers in 2017
8.4 Downstream Buyers

9 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

9.1 Marketing Channel
  9.1.1 Direct Marketing
  9.1.2 Indirect Marketing
  9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
  9.2.1 Pricing Strategy
  9.2.2 Brand Strategy
  9.2.3 Target Client
9.3 Distributors/Traders List

10 MARKET EFFECT FACTORS ANALYSIS

10.1 Technology Progress/Risk
  10.1.1 Substitutes Threat
  10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 UNITED STATES BIOLOGICS & BIOSIMILARS MARKET SIZE (VALUE AND VOLUME) FORECAST (2018-2025)

11.1 United States Biologics & Biosimilars Sales Volume, Revenue Forecast (2018-2025)
11.2 United States Biologics & Biosimilars Sales Volume Forecast by Type (2018-2025)
11.3 United States Biologics & Biosimilars Sales Volume Forecast by Application (2018-2025)
11.4 United States Biologics & Biosimilars Sales Volume Forecast by Region (2018-2025)

12 RESEARCH FINDINGS AND CONCLUSION

13 APPENDIX

13.1 Methodology/Research Approach
  13.1.1 Research Programs/Design
  13.1.2 Market Size Estimation
  13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
  13.2.1 Secondary Sources
  13.2.2 Primary Sources
13.3 Disclaimer

The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Product Picture of Biologics & Biosimilars
Figure United States Biologics & Biosimilars Market Size (K Units) by Type (2013-2025)
Figure United States Biologics & Biosimilars Sales Volume Market Share by Type (Product Category) in 2017
Figure Antibiotic Product Picture
Figure Enzyme Product Picture
Figure Hormone Product Picture
Figure Non-Patented Biological Reagents Product Picture
Figure Other Product Picture
Figure United States Biologics & Biosimilars Market Size (K Units) by Application (2013-2025)
Figure United States Sales Market Share of Biologics & Biosimilars by Application in 2017
Figure Tumor Examples
Table Key Downstream Customer in Tumor
Figure Diabetes Examples
Table Key Downstream Customer in Diabetes
Figure Cardiovascular Examples
Table Key Downstream Customer in Cardiovascular
Figure Hemophilia Examples
Table Key Downstream Customer in Hemophilia
Figure Other Examples
Table Key Downstream Customer in Other
Figure United States Biologics & Biosimilars Market Size (Million USD) by Region (2013-2025)
Figure The West Biologics & Biosimilars Revenue (Million USD) and Growth Rate (2013-2025)
Figure Southwest Biologics & Biosimilars Revenue (Million USD) and Growth Rate (2013-2025)
Figure The Middle Atlantic Biologics & Biosimilars Revenue (Million USD) and Growth Rate (2013-2025)
Figure New England Biologics & Biosimilars Revenue (Million USD) and Growth Rate (2013-2025)
Figure The South of US Biologics & Biosimilars Revenue (Million USD) and Growth Rate (2013-2025)
Figure The Midwest Biologics & Biosimilars Revenue (Million USD) and Growth Rate (2013-2025)
Figure United States Biologics & Biosimilars Sales (K Units) and Growth Rate (2013-2025)
Figure United States Biologics & Biosimilars Revenue (Million USD) and Growth Rate (2013-2025)
Figure United States Biologics & Biosimilars Market Major Players Product Sales Volume (K Units) (2013-2018)
Table United States Biologics & Biosimilars Sales (K Units) of Key Players/Suppliers (2013-2018)
Table United States Biologics & Biosimilars Sales Share by Players/Suppliers (2013-2018)
Figure 2017 United States Biologics & Biosimilars Sales Share by Players/Suppliers
Figure 2017 United States Biologics & Biosimilars Sales Share by Players/Suppliers
Figure United States Biologics & Biosimilars Market Major Players Product Revenue (Million USD) (2013-2018)
Table United States Biologics & Biosimilars Revenue (Million USD) by Players/Suppliers (2013-2018)
Table United States Biologics & Biosimilars Revenue Share by Players/Suppliers (2013-2018)
Figure 2017 United States Biologics & Biosimilars Revenue Share by Players/Suppliers
Figure 2017 United States Biologics & Biosimilars Revenue Share by Players/Suppliers
Table United States Market Biologics & Biosimilars Average Price (USD/Unit) of Key Players/Suppliers (2013-2018)
Figure United States Market Biologics & Biosimilars Average Price (USD/Unit) of Key Players/Suppliers in 2017
Figure United States Biologics & Biosimilars Market Share of Top 3 Players/Suppliers
Figure United States Biologics & Biosimilars Market Share of Top 5 Players/Suppliers
Table United States Players/Suppliers Biologics & Biosimilars Manufacturing Base Distribution and Sales Area
Table United States Players/Suppliers Biologics & Biosimilars Product Category
Table United States Biologics & Biosimilars Sales (K Units) by Region (2013-2018)
Table United States Biologics & Biosimilars Sales Share by Region (2013-2018)
Figure United States Biologics & Biosimilars Sales Share by Region (2013-2018)
Figure United States Biologics & Biosimilars Sales Market Share by Region in 2017
Table United States Biologics & Biosimilars Revenue (Million USD) and Market Share by Region (2013-2018)
Table United States Biologics & Biosimilars Revenue Share by Region (2013-2018)
Figure United States Biologics & Biosimilars Revenue Market Share by Region (2013-2018)
Figure United States Biologics & Biosimilars Revenue Market Share by Region in 2017
Table United States Biologics & Biosimilars Price (USD/Unit) by Region (2013-2018)
Table United States Biologics & Biosimilars Sales (K Units) by Type (2013-2018)
Table United States Biologics & Biosimilars Sales Share by Type (2013-2018)
Figure United States Biologics & Biosimilars Sales Share by Type (2013-2018)
Figure United States Biologics & Biosimilars Sales Market Share by Type in 2017
Table United States Biologics & Biosimilars Revenue (Million USD) and Market Share by Type (2013-2018)
Table United States Biologics & Biosimilars Revenue Share by Type (2013-2018)
Figure Revenue Market Share of Biologics & Biosimilars by Type (2013-2018)
Figure Revenue Market Share of Biologics & Biosimilars by Type in 2017
Table United States Biologics & Biosimilars Price (USD/Unit) by Types (2013-2018)
Figure United States Biologics & Biosimilars Sales Growth Rate by Type (2013-2018)
Table United States Biologics & Biosimilars Sales (K Units) by Application (2013-2018)
Table United States Biologics & Biosimilars Sales Market Share by Application (2013-2018)
Figure United States Biologics & Biosimilars Sales Market Share by Application (2013-2018)
Figure United States Biologics & Biosimilars Sales Market Share by Application in 2017
Table United States Biologics & Biosimilars Sales Growth Rate by Application (2013-2018)
Figure United States Biologics & Biosimilars Sales Growth Rate by Application (2013-2018)
Table fizer Basic Information List
Table fizer Biologics & Biosimilars Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure fizer Biologics & Biosimilars Sales Growth Rate (2013-2018)
Figure fizer Biologics & Biosimilars Sales Market Share in United States (2013-2018)
Figure fizer Biologics & Biosimilars Revenue Market Share in United States (2013-2018)
Table Roche Basic Information List
Table Roche Biologics & Biosimilars Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Roche Biologics & Biosimilars Sales Growth Rate (2013-2018)
Figure Roche Biologics & Biosimilars Sales Market Share in United States (2013-2018)
Figure Roche Biologics & Biosimilars Revenue Market Share in United States (2013-2018)
Table Amgen Basic Information List
Table Amgen Biologics & Biosimilars Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Amgen Biologics & Biosimilars Sales Growth Rate (2013-2018)
Figure Amgen Biologics & Biosimilars Sales Market Share in United States (2013-2018)
Figure Amgen Biologics & Biosimilars Revenue Market Share in United States (2013-2018)
Table AbbVie Basic Information List
Table AbbVie Biologics & Biosimilars Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure AbbVie Biologics & Biosimilars Sales Growth Rate (2013-2018)
Figure AbbVie Biologics & Biosimilars Sales Market Share in United States (2013-2018)
Figure AbbVie Biologics & Biosimilars Revenue Market Share in United States (2013-2018)
Table Sanofi Basic Information List
Table Sanofi Biologics & Biosimilars Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Sanofi Biologics & Biosimilars Sales Growth Rate (2013-2018)
Figure Sanofi Biologics & Biosimilars Sales Market Share in United States (2013-2018)
Figure Sanofi Biologics & Biosimilars Revenue Market Share in United States (2013-2018)
Table Johnson & Johnson Basic Information List
Table Johnson & Johnson Biologics & Biosimilars Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Johnson & Johnson Biologics & Biosimilars Sales Growth Rate (2013-2018)
Figure Johnson & Johnson Biologics & Biosimilars Sales Market Share in United States (2013-2018)
Figure Johnson & Johnson Biologics & Biosimilars Revenue Market Share in United States (2013-2018)
Table Novo Nordisk Basic Information List
Table Novo Nordisk Biologics & Biosimilars Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Novo Nordisk Biologics & Biosimilars Sales Growth Rate (2013-2018)
Figure Novo Nordisk Biologics & Biosimilars Sales Market Share in United States (2013-2018)
Figure Novo Nordisk Biologics & Biosimilars Revenue Market Share in United States (2013-2018)
Table Novartis Basic Information List
Table Novartis Biologics & Biosimilars Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Novartis Biologics & Biosimilars Sales Growth Rate (2013-2018)
Figure Novartis Biologics & Biosimilars Sales Market Share in United States (2013-2018)
Figure Novartis Biologics & Biosimilars Revenue Market Share in United States (2013-2018)
Table Merck Basic Information List
Table Merck Biologics & Biosimilars Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Merck Biologics & Biosimilars Sales Growth Rate (2013-2018)
Figure Merck Biologics & Biosimilars Sales Market Share in United States (2013-2018)
Figure Merck Biologics & Biosimilars Revenue Market Share in United States (2013-2018)
Table Lilly Basic Information List
Table Lilly Biologics & Biosimilars Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Lilly Biologics & Biosimilars Sales Growth Rate (2013-2018)
Figure Lilly Biologics & Biosimilars Sales Market Share in United States (2013-2018)
Figure Lilly Biologics & Biosimilars Revenue Market Share in United States (2013-2018)
Table 3sbio Basic Information List
Table Changchun High Tech Basic Information List
Table CP Guojian Pharmacy Basic Information List
Table Biotech Pharma Basic Information List
Table Gelgen Biopharma Basic Information List
Table Sandoz Basic Information List
Table Teva Basic Information List
Table Hospira Basic Information List
Table Mylan Basic Information List
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Biologics & Biosimilars
Figure Manufacturing Process Analysis of Biologics & Biosimilars
Figure Biologics & Biosimilars Industrial Chain Analysis
Table Raw Materials Sources of Biologics & Biosimilars Major Players/Suppliers in 2017
Table Major Buyers of Biologics & Biosimilars
Table Distributors/Traders List
Figure United States Biologics & Biosimilars Sales Volume (K Units) and Growth Rate Forecast (2018-2025)
Figure United States Biologics & Biosimilars Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Figure United States Biologics & Biosimilars Price (USD/Unit) Trend Forecast (2018-2025)
Table United States Biologics & Biosimilars Sales Volume (K Units) Forecast by Type (2018-2025)
Figure United States Biologics & Biosimilars Sales Volume (K Units) Forecast by Type (2018-2025)
Figure United States Biologics & Biosimilars Sales Volume (K Units) Forecast by Type in 2025
Table United States Biologics & Biosimilars Sales Volume (K Units) Forecast by Application (2018-2025)
Figure United States Biologics & Biosimilars Sales Volume (K Units) Forecast by Application (2018-2025)
Figure United States Biologics & Biosimilars Sales Volume (K Units) Forecast by Application in 2025
Table United States Biologics & Biosimilars Sales Volume (K Units) Forecast by Region (2018-2025)
Table United States Biologics & Biosimilars Sales Volume Share Forecast by Region (2018-2025)
Figure United States Biologics & Biosimilars Sales Volume Share Forecast by Region (2018-2025)
Figure United States Biologics & Biosimilars Sales Volume Share Forecast by Region in 2025
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources